Heterodimeric Fc-fused IL12 shows potent antitumor activity by generating memory CD8+ T cells
出版年份 2018 全文链接
标题
Heterodimeric Fc-fused IL12 shows potent antitumor activity by generating memory CD8+ T cells
作者
关键词
-
出版物
OncoImmunology
Volume 7, Issue 7, Pages e1438800
出版商
Informa UK Limited
发表日期
2018-02-12
DOI
10.1080/2162402x.2018.1438800
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines
- (2017) Christian Klein et al. OncoImmunology
- Immunocytokines and bispecific antibodies: two complementary strategies for the selective activation of immune cells at the tumor site
- (2016) Jonathan D. Kiefer et al. IMMUNOLOGICAL REVIEWS
- Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins
- (2016) Ji-Hee Ha et al. Frontiers in Immunology
- An Excess of the Proinflammatory Cytokines IFN-γ and IL-12 Impairs the Development of the Memory CD8+T Cell Response toChlamydia trachomatis
- (2015) Xuqing Zhang et al. JOURNAL OF IMMUNOLOGY
- IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases
- (2015) Michele W L Teng et al. NATURE MEDICINE
- Engineering of Immunoglobulin Fc Heterodimers Using Yeast Surface-Displayed Combinatorial Fc Library Screening
- (2015) Hye-Ji Choi et al. PLoS One
- Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution
- (2015) Alice Tzeng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The immunocytokine NHS-IL12 as a potential cancer therapeutic
- (2015) Jonathan Fallon et al. Oncotarget
- Interleukin 12: still a promising candidate for tumor immunotherapy?
- (2014) Witold Lasek et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- New insights into IL-12-mediated tumor suppression
- (2014) S Tugues et al. CELL DEATH AND DIFFERENTIATION
- Tumor cells loaded with α-galactosylceramide promote therapeutic NKT-dependent anti-tumor immunity in multiple myeloma
- (2013) Sungyoul Hong et al. IMMUNOLOGY LETTERS
- IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo
- (2013) Gabriel R. Starbeck-Miller et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Heterodimeric Fc-Based Bispecific Antibody Simultaneously Targeting VEGFR-2 and Met Exhibits Potent Antitumor Activity
- (2013) H.-J. Choi et al. MOLECULAR CANCER THERAPEUTICS
- The Antibody-Based Delivery of Interleukin-12 to the Tumor Neovasculature Eradicates Murine Models of Cancer in Combination with Paclitaxel
- (2012) N. Pasche et al. CLINICAL CANCER RESEARCH
- CD8+ T Cells Sabotage Their Own Memory Potential through IFN- -Dependent Modification of the IL-12/IL-15 Receptor Axis on Dendritic Cells
- (2012) F. J. Kohlhapp et al. JOURNAL OF IMMUNOLOGY
- Crosstalk between Human IgG Isotypes and Murine Effector Cells
- (2012) M. B. Overdijk et al. JOURNAL OF IMMUNOLOGY
- IL-12 family cytokines: immunological playmakers
- (2012) Dario A A Vignali et al. NATURE IMMUNOLOGY
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity
- (2010) SaeGwang Park et al. CANCER CELL
- Granzymes in cancer and immunity
- (2010) S P Cullen et al. CELL DEATH AND DIFFERENTIATION
- Memories that last forever: strategies for optimizing vaccine T-cell memory
- (2009) J. D. Ahlers et al. BLOOD
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started